Michael Friedman

Michael Friedman currently serves as the Executive Director of Global Medical Affairs Strategy at Apellis Pharmaceuticals, focusing on geographic atrophy. With extensive experience in medical affairs and clinical development, Michael has held key positions, including Executive Director at Adverum Biotechnologies and Senior Medical Director at Novartis Gene Therapies, where contributions included leadership in gene therapy trials and successful product launches. Michael's dedication to rare diseases is also demonstrated through active involvement with the ML4 Foundation, providing scientific guidance on grant requests related to lysosomal storage disorders and gene therapy. Michael's educational background includes a Ph.D. in Cellular and Molecular Biology from the University of Michigan.